2-(4-Chloro-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

(1R,2R)-2-Iodocyclopropanecarboxylic acid, 95.0%, 250mg

(2R,3R)-2-Methyl-3-((methylsulfonyl)methyl)azetidine hydrochloride, 98%, 1g

ethyl (2Z)-2-chloro-2-[2-(2,3-dimethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

4-Bromo-2-hydrazinylpyridine, 95.0%, 5g

Matraces de fondo redondo ROTILABO® con borde rebordeado, cuello ancho, 1000 ml, 1 pieza

2-(4-chloro-2-methylphenoxy)acetic acid, 97.0%, 500mg

5-Bromo-1,3,4-thiadiazol-2-ylamine, 99.0%, 25g

3-fluoro-N-[5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]benzamide, 95.0%, 1g

(R)-3-Methyl-pyrrolidine hydrochloride, 97.0%, 1g

Polyvinylpyrrolidone K 15 Average Molecular Wt. 10000500g

CEFOXITIN, 95%, 25g

Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 97.0%, 250mg